Lenzilumab Biosimilar - Research Grade

Lenzilumab Biosimilar - Research Grade, Human IgG1(K214R)-Kappa

Target: CSF2.

Specificity: Detects human CSF2.

Purification method: This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.

Background: Uses the same sequence as the therapeutic antibody Lenzilumab.

Concentration: 5mg/ml.

Formulation: Sterile, preservative-free, solution in PBS. BSA and Azide free.

Purity: ≥95% monomer by analytical SEC, >95% by SDS Page.

Endotoxin: <1EU/mg Determined by LAL gel clotting assay.

Use: Products are for research use only. Not for use in diagnostic or therapeutic procedures.

• SKU: ICH5166-50MG
• Manufacturer: Ichorbio
• Manufacturer SKU: ICH5166-50MG
• Package Unit: 50mg
• Quantity Unit: STK
• Reactivity: Human
• Clonality: Monoclonal
• Application: Functional Assay
• Isotype: Human IgG1(K214R)-Kappa